A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study)
Clinical trial NCT04364763 · TERMINATED
Trial details
- NCT number
- NCT04364763
- Sponsor
- Renibus Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-05
- Primary completion
- 2021-09-02
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.